Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYOFLAME-19
2024-516463-84-00Phase 3Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in Not applicable (see rationale) and post-COVID syndrome comparing Prednisolone + losartan with Placebo (2 arms). Primary endpoint: Change in left ventricular ejection fraction at week 16. Started Oct 2024; status: completed.
02
Drugs
prednisolonelosartan
03
Conditions
Not applicable (see rationale)post-COVID syndrome
Beyond the preview
Go deeper on 2024-516463-84-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516463-84-00.